The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Espinosa, A.
Right arrow Articles by Wahren-Herlenius, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Espinosa, A.
Right arrow Articles by Wahren-Herlenius, M.
The Journal of Immunology, 2006, 176: 6277-6285.
Copyright © 2006 by The American Association of Immunologists

The Sjögren’s Syndrome-Associated Autoantigen Ro52 Is an E3 Ligase That Regulates Proliferation and Cell Death1

Alexander Espinosa*, Wei Zhou2,*, Monica Ek2,*, Malin Hedlund*, Susanna Brauner*, Karin Popovic{dagger}, Linn Horvath*, Therese Wallerskog*, Mohamed Oukka{ddagger}, Filippa Nyberg{dagger}, Vijay K. Kuchroo3,{ddagger} and Marie Wahren-Herlenius*

* Rheumatology Unit, Department of Medicine and {dagger} Department of Dermatology, Karolinska Institutet at Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden; and {ddagger} Center for Neurologic Diseases, Brigham and Woman’s Hospital, Harvard Medical School, Boston, MA 02115

Patients affected by Sjögren’s syndrome and systemic lupus erythematosus (SLE) carry autoantibodies to an intracellular protein denoted Ro52. Although the serologic presence of Ro52 autoantibodies is used clinically for diagnostic purposes, the function of the protein or why it is targeted as an autoantigen in several rheumatic conditions has not been elucidated. In this study, we show that the expression of Ro52 is significantly increased in PBMC of patients with Sjögren’s syndrome and SLE, and demonstrate that Ro52 is a RING-dependent E3 ligase involved in ubiquitination. Overexpression of Ro52, but not of Ro52 lacking the RING domain, in a mouse B cell line lead to decreased growth in steady state and increased cell death after activation via the CD40 pathway. The role of Ro52 in activation-mediated cell death was further confirmed as a reduction in Ro52 expression restored cell viability. These findings suggest that the increased expression of the Ro52 autoantigen in patients may be directly involved in the reduced cellular proliferation and increased apoptotic cell death observed in Sjögren’s syndrome and SLE, and may thus contribute to the autoantigenic load and induction of autoimmune B and T cell responses observed in rheumatic patients.


Related articles in The JI:

IN THIS ISSUE

The JI 2006 176: 5699-5700. [Full Text]  



This article has been cited by other articles:


Home page
JEMHome page
A. Espinosa, V. Dardalhon, S. Brauner, A. Ambrosi, R. Higgs, F. J. Quintana, M. Sjostrand, M.-L. Eloranta, J. Ni Gabhann, O. Winqvist, et al.
Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway
J. Exp. Med., August 3, 2009; 206(8): 1661 - 1671.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
B. J. Gu, C. Rathsam, L. Stokes, A. B. McGeachie, and J. S. Wiley
Extracellular ATP dissociates nonmuscle myosin from P2X7 complex: this dissociation regulates P2X7 pore formation
Am J Physiol Cell Physiol, August 1, 2009; 297(2): C430 - C439.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Yoshimi, T.-H. Chang, H. Wang, T. Atsumi, H. C. Morse III, and K. Ozato
Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-{kappa}B-Dependent Cytokine Expression in Fibroblasts
J. Immunol., June 15, 2009; 182(12): 7527 - 7538.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Yang, H.-X. Shi, X.-Y. Liu, Y.-F. Shan, B. Wei, S. Chen, and C. Wang
TRIM21 Is Essential to Sustain IFN Regulatory Factor 3 Activation during Antiviral Response
J. Immunol., March 15, 2009; 182(6): 3782 - 3792.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Y. Kim and K. Ozato
The Sequestosome 1/p62 Attenuates Cytokine Gene Expression in Activated Macrophages by Inhibiting IFN Regulatory Factor 8 and TNF Receptor-Associated Factor 6/NF-{kappa}B Activity
J. Immunol., February 15, 2009; 182(4): 2131 - 2140.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Higgs, J. N. Gabhann, N. B. Larbi, E. P. Breen, K. A. Fitzgerald, and C. A. Jefferies
The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-{beta} Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF3
J. Immunol., August 1, 2008; 181(3): 1780 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Miyajima, S. Maruyama, M. Bohgaki, S. Kano, M. Shigemura, N. Shinohara, K. Nonomura, and S. Hatakeyama
TRIM68 Regulates Ligand-Dependent Transcription of Androgen Receptor in Prostate Cancer Cells
Cancer Res., May 1, 2008; 68(9): 3486 - 3494.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
V. Barkauskaite, M. Ek, K. Popovic, H.E. Harris, M. Wahren-Herlenius, and F. Nyberg
Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus
Lupus, October 1, 2007; 16(10): 794 - 802.
[Abstract] [PDF]


Home page
J. Immunol.Home page
H. J. Kong, D. E. Anderson, C. H. Lee, M. K. Jang, T. Tamura, P. Tailor, H. K. Cho, J. Cheong, H. Xiong, H. C. Morse III, et al.
Cutting Edge: Autoantigen Ro52 Is an Interferon Inducible E3 Ligase That Ubiquitinates IRF-8 and Enhances Cytokine Expression in Macrophages
J. Immunol., July 1, 2007; 179(1): 26 - 30.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.